Is pharmaceutical ingredients been imported from China?
Reportedly the indian pharmaceutical industry is expected to register a growth of 14.2 percent in the second quarter of the current financial year contrary to 4.8 percent in the first quarter, a study by Information and Credit Rating Agency (ICRA) has found. Meanwhile the lower capacity utilization is largely contributed by restricted movement of personnel and availability of non-critical raw material (like packaging material) during the lockdown period in India. indian players hold two to four months of inventory (raw material and finished goods) and similar levels in the distribution channel (finished goods) which will largely suffice demand in the near term till the situation normalizes.
Perhaps the domestic pharmaceutical industry is highly dependent on imports, with more than 60 percent of its active pharmaceutical ingredients (API) requirement being imported, and in some, specific APIs like cephalosporins, azithromycin and penicillin, the dependence is as high as 80 percent to 90 percent.
"The recent introduction of Rs 10,000.0 crore bulk drugs park and production linked incentives for API manufacturers by the Union government will lead to reduced dependence for the domestic formulators on imports from china and augurs well in the long run to manage supply disruptions. The incentive scheme covers 53 APIs which are critical from import dependence on china with few API/KSM being entirely imported," states the ICRA study.
How Indians spending their Money during the ongoing Coronavirus outbreak?
Bollywood's Bigg Boss 14 commences from September 27
PM Modi dialed AP CM inquired about mishap in Covid care facility in Vijayawada
Covid report of Amit Shah has come as Negative
Ministry of Defence ready for Make in India push
Source: India Herald - SIBY JEYYA